Search results
Contraline’s male contraceptive device trial gets sperm analysis collab
Medical Device Network via Yahoo Finance· 1 day agoDNA Diagnostics Centre (DDC) will supply a home test kit for sperm detection to Contraline’s...
More Women in Africa Are Using Long-Acting Contraception, Changing Lives
New York Times· 5 days agoMethods such as hormonal implants and injections are reaching remote areas, providing more...
Misinformation around Birth Control Online Is a Form of Contraception Coercion
Scientific American· 1 day agoThe recent Supreme Court ruling in the case about mifepristone, a medication abortion drug, offered...
Women’s health: How innovations in implantable drug delivery systems are improving lives
Medical Device Network via Yahoo Finance· 4 days agoImplantable devices are a highly effective method of drug delivery for women’s health applications....
The Supreme Court Overruled Roe Two Years Ago, Ending Right To Abortion. Birth Control May Be Next.
Forbes· 1 day agoJustice Clarence Thomas laid out that, in the future, the court should reconsider other rulings that relied on the same principles as Roe – including Griswold v. Connecticut, the Court’s 1965 ...
Tuesday Briefing
New York Times· 5 days agoIsrael’s prime minister dissolved his war cabinet.
Tuesday Briefing: Netanyahu Disbands His War Cabinet
New York Times· 5 days agoAlso, President Vladimir Putin’s state visit to North Korea.
Struggling with ‘bacne?’ New treatments can help an embarrassing problem.
Washington Post· 1 day agoBacne, the colloquial term for back acne, is a common and stubborn condition that has been shown to...
Polycystic Ovarian Syndrome: New Science Offers Old Remedy
Medscape· 4 days agoAn ancient Chinese remedy for malaria could offer new hope to the 10% of reproductive-age women...
Agile Therapeutics (NASDAQ:AGRX) Coverage Initiated by Analysts at StockNews.com
ETF DAILY NEWS· 6 days agoStockNews.com started coverage on shares of Agile Therapeutics (NASDAQ:AGRX – Free Report) in a research report report published on Saturday. The firm issued a sell rating on the specialty pharmaceutical ...